Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: A pilot study

Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 746-757

  Kawaguchi, Takumi ^a   Shiba, Naoto ^b   Maeda, Takashi ^b   Matsugaki, Toru ^a   Takano, Yoshio ^a,b   Itou, Minoru ^a   Sakata, Masahiro ^a   Taniguchi, Eitaro ^a   Nagata, Kensei ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Exercise; Insulin resistance; Myokine; Nonalcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERLEUKIN 6;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; HAMSTRING; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MALE; METABOLIC RATE; MUSCLE CONTRACTION; MUSCLE MASS; MUSCLE TRAINING; NONALCOHOLIC FATTY LIVER; PATIENT COUNSELING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUADRICEPS FEMORIS MUSCLE; THERAPY EFFECT; VOLUNTARY MOVEMENT;

ALANINE TRANSAMINASE; DIRECTIVE COUNSELING; ELECTRIC STIMULATION THERAPY; EXERCISE THERAPY; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; LIFE STYLE; MALE; MIDDLE AGED; MUSCLE CONTRACTION; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; RISK FACTORS;

EID: 79960251805     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0378-x     Document Type: Article

References (59)

1. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112-7. (Pubitemid 30044177)
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95. (Pubitemid 39657013)
3. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology. 2008;134:1682-98. (Pubitemid 351615413)
4. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113-21. (Pubitemid 41002048)
5. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis. 2010;42:272-82.
6. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49:608-12.
7. Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010;51: 595-602.
8. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679-89.
9. Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol. 2005;100: 1072-81. (Pubitemid 40769044)
10. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 2007;86:285-300. (Pubitemid 47256910)
11. Devries MC, Samjoo IA, Hamadeh MJ, Tarnopolsky MA. Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women. Obesity (Silver Spring). 2008;16: 2281-8.
12. Shah K, Stufflebam A, Hilton TN, Sinacore DR, Klein S, Villa-real DT. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring). 2009;17:2162-8.
13. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27:103-7. (Pubitemid 27357062)
14. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009;49:306-17.
15. Terzis G, Georgiadis G, Stratakos G, Vogiatzis I, Kavouras S, Manta P, et al. Resistance exercise-induced increase in muscle mass correlates with p70S6 kinase phosphorylation in human subjects. Eur J Appl Physiol. 2008;102:145-52. (Pubitemid 350142379)
16. van Baak MA. Physical activity and energy balance. Public Health Nutr. 1999;2:335-9. (Pubitemid 29529009)
17. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88: 1379-406.
18. Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab. 2006;290: E961-7.
19. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48:449-57.
20. Frith J, Day CP, Robinson L, Elliott C, Jones DE, Newton JL. Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol. 2010;52:112-6.
21. Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004;53:413-9. (Pubitemid 38241340)
22. Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol. 2005;43:1060-6. (Pubitemid 41627993)
23. Yanagi T, Shiba N, Maeda T, Iwasa K, Umezu Y, Tagawa Y, et al. Agonist contractions against electrically stimulated antagonists. Arch Phys Med Rehabil. 2003;84:843-8. (Pubitemid 36682331)
24. Yoshimitsu K, Shiba N, Matsuse H, Takano Y, Matsugaki T, Inada T, et al. Development of a training method for weightless environment using both electrical stimulation and voluntary muscle contraction. Tohoku J Exp Med. 2010;220:83-93.
25. Matsuse H, Shiba N, Umezu Y, Nago T, Maeda T, Tagawa Y, et al. Effects of a hybrid exercise on the activities of myogenic enzymes in plasma. Kurume Med J. 2006;53:47-51. (Pubitemid 46456068)
26. Iwasaki T, Shiba N, Matsuse H, Nago T, Umezu Y, Tagawa Y, et al. Improvement in knee extension strength through training by means of combined electrical stimulation and voluntary muscle contraction. Tohoku J Exp Med. 2006;209:33-40.
27. Nago T, Umezu Y, Shiba N, Matsuse H, Maeda T, Tagawa Y, et al. Muscle maintenance by volitional contraction against applied electrical stimulation. Kurume Med J. 2007;54:35-40. (Pubitemid 351486932)
28. Takano Y, Haneda Y, Maeda T, Sakai Y, Matsuse H, Kawaguchi T, et al. Increasing muscle strength and mass of thigh in elderly people with the hybrid-training method of electrical stimulation and volitional contraction. Tohoku J Exp Med. 2010;221:77-85.
29. Matsuse H, Shiba N, Umezu Y, Nago T, Tagawa Y, Kakuma T, et al. Muscle training by means of combined electrical stimulation and volitional contraction. Aviat Space Environ Med. 2006;77:581-5.
30. American Gastroenterological Association. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1702-4.
31. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745-50. (Pubitemid 34977081)
32. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22:775-7. (Pubitemid 46911045)
33. Oza N, Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Horie H, et al. A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol. 2009;44:1203-8.
34. Cunningham JJ. A reanalysis of the factors influencing basal metabolic rate in normal adults. Am J Clin Nutr. 1980;33:2372-4.
35. Iwasa M, Hara N, Iwata K, Ishidome M, Sugimoto R, Tanaka H, et al. Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease. Hepatol Res. 2010;40: 1188-94.
36. Torimoto K, Hirayama A, Samma S, Yoshida K, Fujimoto K, Hirao Y. The relationship between nocturnal polyuria and the distribution of body fluid: assessment by bioelectric impedance analysis. J Urol. 2009;181:219-24. (discussion 24).
37. Sasaki N, Takeda S, Saito T, Ando Y, Kusano E. Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis. Nippon Jinzo Gakkai Shi. 2009;51:476-83.
38. Hara N, Iwasa M, Iwata K, Miyachi H, Tanaka H, Takeo M, et al. Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites. Hepatol Res. 2009;39:1072-9.
39. Kawaguchi T, Taniguchi E, Itou M, Ibi R, Okada T, Mutou M, et al. Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices. Int J Mol Med. 2008;22:589-94.
40. Heitmann BL. Impedance: a valid method in assessment of body composition? Eur J Clin Nutr. 1994;48:228-40. (Pubitemid 24123693)
41. Kushner RF, Schoeller DA. Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr. 1986;44: 417-24. (Pubitemid 16052634)
42. Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S, et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol. 2007;102:570-6. (Pubitemid 46328143)
43. Kawaguchi T, Kuromatsu R, Ide T, Taniguchi E, Itou M, Sakata M, et al. Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases. Kurume Med J. 2009;56:9-15.
44. Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol. 2004;165:1499-508. (Pubitemid 39435150)
45. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9. (Pubitemid 15018832)
46. Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006;41:462-9. (Pubitemid 43941913)
47. Koda M, Kawakami M, Murawaki Y, Senda M. The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies. J Gastroenterol. 2007;42:897-903. (Pubitemid 350142770)
48. Sakurai M, Takamura T, Ota T, Ando H, Akahori H, Kaji K, et al. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol. 2007;42:312-7. (Pubitemid 46681707)
49. Porcari JP, McLean KP, Foster C, Kernozek T, Crenshaw B, Swenson C. Effects of electrical muscle stimulation on body composition, muscle strength, and physical appearance. J Strength Cond Res. 2002;16:165-72.
50. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119:S10-6.
51. Klip A, Paquet MR. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care. 1990;13: 228-43. (Pubitemid 20092110)
52. Chilibeck PD, Bell G, Jeon J, Weiss CB, Murdoch G, MacLean I, et al. Functional electrical stimulation exercise increases GLUT-1 and GLUT-4 in paralyzed skeletal muscle. Metabolism. 1999;48:1409-13. (Pubitemid 29536440)
53. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest. 1987;80:415-24.
54. Oberbach A, Bossenz Y, Lehmann S, Niebauer J, Adams V, Paschke R, et al. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care. 2006;29:895-900. (Pubitemid 44115313)
55. Mohr T, Andersen JL, Biering-Sorensen F, Galbo H, Bangsbo J, Wagner A, et al. Long-term adaptation to electrically induced cycle training in severe spinal cord injured individuals. Spinal Cord. 1997;35:1-16. (Pubitemid 27049520)
56. Feve B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5: 305-11.
57. Marra F, Bertolani C. Adipokines in liver diseases. Hepatology. 2009;50:957-69.
58. Kohut ML, McCann DA, Russell DW, Konopka DN, Cunnick JE, Franke WD, et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun. 2006;20:201-9.
59. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46:1594-603. (Pubitemid 38005321)